QXO
- Product code
- QXO
- Device name
- Cardiovascular Machine Learning-Based Notification Software
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.2380
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 2 (all years; only the last 3 years are listed here)
FDA classification definition
Cardiovascular machine learning-based notification software employs machine learning techniques to suggest the likelihood of a cardiovascular disease or condition for further referral or diagnostic follow-up. The software identifies a single condition based on one or more non-invasive physiological inputs as part of routine medical care. It is intended as the basis for further testing and is not intended to provide diagnostic quality output. It is not intended to identify or detect arrhythmias.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K260332 | 2026-06-08 | Pathwai, Inc. | EchoNext |
Official FDA classification page: QXO
Classification and pathway per current FDA publications. Data from openFDA (CC0).